ZEISS Group

Solutions that shape technological progress

Diagnose & Treat

Researching into Micro- and Nanostructures

See better

Assure Industrial Quality Excellence

Enabling Chip Manufacturers

Photograph & Film

Skater boy practicing at the skate park

Create Virtual Worlds

Observe & Experience

Latest on the COVID-19 Situation

In response to the coronavirus pandemic, ZEISS has taken comprehensive measures to protect employees and maintain smart business continuity.

In order to continue supporting customers and partners as best as possible, at ZEISS we are doing everything we can to protect our employees’ health and safety as well as maintain production in our plants and ensure our service operations.

In January, ZEISS set up a dedicated task force. We are closely assessing the latest developments together with government agencies and healthcare authorities on an ongoing basis. Decisions are made daily regarding the most sensible measures for ZEISS to take.

Of course, we will continue to be available for our customers as best we can. Some employees in individual areas are currently working remotely but can still be reached at their usual phone numbers and email addresses.

However, should our customers experience any disruptions in service at some of our sites and sales offices, we can also be contacted on these numbers.

All over the world, the company and its employees are joining the fight against the spread and consequences of the coronavirus pandemic. Read more

Discover ZEISS

Fascinating insights into the world of optics

World Cancer Day

The role of ZEISS in fighting cancer

more

More than Just a Pair of Glasses:

How ZEISS Lenses Influenced Monet`s Creative Process

more
more

Underwater adventures of ZEISS lenses

Get inspired

News & Events

News from the ZEISS Group

8 February 2021

Successful start to FY 2020/21 for Carl Zeiss Meditec

Press Release

Successful start to FY 2020/21 for Carl Zeiss Meditec

Carl Zeiss Meditec generated revenue of €368.9m in the first three months of fiscal year 2020/21 (prior year: €369.7m), corresponding to a decline of just -0.2% (adjusted for currency effects: +2.6%) compared with the year-ago period, which had not yet been impacted by the COVID-19 pandemic. Earnings before interest and tax (EBIT) increased to €73.4m (prior year: €56.8m). The EBIT margin was 19.9% (prior year: 15.4%).

28 January 2021

ZEISS Innovation Hub @ KIT Celebrates One-Year Anniversary

Press Release

The ZEISS Innovation Hub @ KIT on the North Campus of the Karlsruhe Institute of Technology (KIT).

The ZEISS Innovation Hub @ KIT on the North Campus of the Karlsruhe Institute of Technology (KIT) commenced operations back in January 2020, but has not been able to hold an official opening due to the pandemic – until yesterday, that is, when the opening was honored in a virtual ceremony.

19 January 2021

Carl Zeiss Meditec AG achieves increase in profit in first quarter 2020/21

Press Release

Carl Zeiss Meditec reports decline in revenue due to COVID-19 pandemic

Carl Zeiss Meditec AG (ISIN: DE0005313704) has achieved revenue of EUR 368.9 million in the first quarter of fiscal year 2020/21 (previous year: EUR 369.7 million). This corresponds to a revenue development of -0.2% vs. the past year (after adjustment for currency effects: +2.6%).